Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial

George Maynard, Ramakrishnan Kannan, Jian Liu, Weiwei Wang, Tu Kiet T. Lam, Xingxing Wang, Crista Adamson, Craig Hackett, Jan M. Schwab, Charles Liu, Donald P. Leslie, David Chen, Ralph Marino, Ross Zafonte, Adam Flanders, Gilbert Block, Erika Smith, Stephen M. Strittmatter

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Neuroscience

Keyphrases